NXTC Valuation

NextCure Inc

Add to Watchlist

Advanced Chart

5.260

+0.06(1.154%)1D

Overview
Forecast
Valuation
Earnings

NXTC Relative Valuation

NXTC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NXTC is overvalued; if below, it's undervalued.

Historical Valuation

NextCure Inc (NXTC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.65. The fair price of NextCure Inc (NXTC) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：5.12

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.22

P/B

Median3y

0.35

Median5y

0.53

-361.98

FCF Yield

Median3y

-151.20

Median5y

-101.85

Competitors Valuation Multiple

The average P/S ratio for NXTC's competitors is 0.64, providing a benchmark for relative valuation. NextCure Inc Corp (NXTC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap